Thermo Fisher Scientific

TMO · NYSE · USD

$654.80+0.35%+$2.29

Close · October 2, 2026

At a glance

Revenue growth: +3.91%; 2025 vs 2024
Net income growth: +5.82%; 2025 vs 2024
Net margin: 15.0%; 2024: 14.8%

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

Income statement · Quarterly
Item	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023
Total revenue	11,994	11,005	12,215	11,122	10,855	10,364	11,395	10,598	10,541	10,345	10,886	10,574
Cost of revenue	7,084	6,561	7,171	6,529	6,436	6,118	6,551	6,261	6,194	6,125	6,471	6,244
Gross profit	4,910	4,444	5,044	4,593	4,419	4,246	4,844	4,337	4,347	4,220	4,415	4,330
Selling, general and administrative	2,297	2,138	2,237	2,103	2,120	2,064	2,178	2,079	2,175	2,164	2,096	2,035
Research and development	364	336	356	346	352	342	374	346	339	331	327	319
Operating income	2,249	1,969	2,586	2,144	1,947	1,840	2,262	1,912	1,833	1,725	1,991	1,976
EBIT	2,249	1,969	2,586	2,144	1,947	1,840	2,262	1,912	1,833	1,725	1,991	1,976
EBITDA	3,068	2,703	3,314	2,815	2,633	2,545	3,004	2,662	2,613	2,561	2,830	2,829
Interest expense	401	354	365	347	404	303	317	356	354	363	390	359
Pre-tax income	1,908	1,726	2,123	1,828	1,711	1,606	1,974	1,729	1,682	1,613	1,739	1,748
Income tax	167	70.0	153	207	92.0	95.0	150	99.0	128	281	133	53.0
Net income	1,736	1,651	1,964	1,616	1,617	1,507	1,830	1,630	1,548	1,328	1,630	1,715
Net income to common shareholders	1,736	1,651	1,964	1,616	1,617	1,507	1,830	1,630	1,548	1,328	1,630	1,715
Basic EPS	4.68	4.44	5.22	4.28	4.28	3.99	4.79	4.27	4.05	3.48	4.21	4.44
Diluted EPS	4.68	4.43	5.22	4.27	4.28	3.98	4.78	4.25	4.04	3.46	4.20	4.42
Average shares (basic)	371	372	376	378	378	378	382	382	382	382	387	386
Average shares (diluted)	371	373	377	378	378	379	383	384	383	384	388	388
Dividend per share	0.47	0.47	0.43	0.43	0.43	0.43	0.39	0.39	0.39	0.39	0.35	0.35